Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF.

[1]  M. Gheorghiade,et al.  Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry , 2015, Journal of cardiovascular medicine.

[2]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[3]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[4]  R. Califf,et al.  Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From the Acute Study Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) , 2013, Circulation. Cardiovascular quality and outcomes.

[5]  R. Califf,et al.  Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?: Findings From ASCEND-HF , 2013, Circulation. Heart failure.

[6]  B. Massie,et al.  Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. , 2013, JACC. Heart failure.

[7]  V. Hasselblad,et al.  Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF , 2013, European journal of heart failure.

[8]  Serene I. Chen,et al.  Variation Exists in Rates of Admission to Intensive Care Units for Heart Failure Patients Across Hospitals in the United States , 2013, Circulation.

[9]  R. McKelvie,et al.  The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. , 2013, The Canadian journal of cardiology.

[10]  K. Anstrom,et al.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.

[11]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[12]  V. Hasselblad,et al.  Clinical Outcomes at 180 days in the ASCEND-HF Trial: Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure , 2011 .

[13]  L. Deckelbaum,et al.  Effect of nesiritide in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[14]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[15]  Hude Quan,et al.  Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? , 2011, European journal of heart failure.

[16]  R. Porcher,et al.  Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) , 2011, Intensive Care Medicine.

[17]  A. Mebazaa,et al.  International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes , 2010, European journal of heart failure.

[18]  M. Gheorghiade,et al.  Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial. , 2010, International journal of cardiology.

[19]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[20]  Derek C. Angus,et al.  Three-year outcomes for Medicare beneficiaries who survive intensive care. , 2010, JAMA.

[21]  P. Austin.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.

[22]  V. Hasselblad,et al.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). , 2009, American heart journal.

[23]  K. Swedberg,et al.  Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. , 2008, Journal of the American College of Cardiology.

[24]  C. O'connor,et al.  Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, American heart journal.

[25]  George A Mensah,et al.  Heart failure-related hospitalization in the U.S., 1979 to 2004. , 2008, Journal of the American College of Cardiology.

[26]  J. Cleland,et al.  NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland , 2007, Heart.

[27]  R. Becker,et al.  Cardiology and the critical care crisis: a perspective. , 2007, Journal of the American College of Cardiology.

[28]  Nancy M Albert,et al.  Association between performance measures and clinical outcomes for patients hospitalized with heart failure. , 2007, JAMA.

[29]  P. Ponikowski,et al.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.

[30]  C. Yancy,et al.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. , 2006, Journal of the American College of Cardiology.

[31]  Harlan M Krumholz,et al.  ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society , 2005, Circulation.

[32]  C. Yancy,et al.  Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. , 2005, Archives of internal medicine.

[33]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[34]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[35]  Stephen R Cole,et al.  Adjusted survival curves with inverse probability weights , 2004, Comput. Methods Programs Biomed..

[36]  C. Ract,et al.  Critically ill old and the oldest-old patients in intensive care: short- and long-term outcomes , 2003, Intensive Care Medicine.

[37]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[38]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[39]  W. Pan.  Akaike's Information Criterion in Generalized Estimating Equations , 2001, Biometrics.

[40]  E. Guthrie,et al.  Survival, morbidity, and quality of life after discharge from intensive care , 2000, Critical care medicine.

[41]  S. Nasraway,et al.  Survivors of catastrophic illness: Outcome after direct transfer from intensive care to extended care facilities , 2000, Critical care medicine.

[42]  Paul D. Allison,et al.  Survival analysis using sas®: a practical guide , 1995 .

[43]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[44]  G. Fonarow,et al.  Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2007, American heart journal.